Carnosic acid-induced co-self-assembly of metal-peptide complexes into a nanocluster-based framework with tumor-specific accumulation for augmented immunotherapy

Chiral Protein Supraparticles for Tumor Suppression and Synergistic Immunotherapy: An Enabling Strategy for Bioactive Supramolecular Chirality Construction

(2020) Jin Yan et al.   NANO LETTERS

Structurally divergent dynamic combinatorial chemistry on racemic mixtures

(2020) Tiberiu-M. Gianga et al.   Nature Communications

Resurrecting a p53 peptide activator - An enabling nanoengineering strategy for peptide therapeutics

(2020) Wangxiao He et al.   JOURNAL OF CONTROLLED RELEASE

Self‐Synthesizing Nanorods from Dynamic Combinatorial Libraries against Drug Resistant Cancer

(2020) Yu Cao et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

De novo supraparticle construction by a self-assembled Janus cyclopeptide to tame hydrophilic microRNA and hydrophobic molecule for anti-tumor cocktail therapy and augmented immunity

(2020) Junjun She et al.   CHEMICAL ENGINEERING JOURNAL

Self-Assembly of Therapeutic Peptide into Stimuli-Responsive Clustered Nanohybrids for Cancer-Targeted Therapy

(2019) Wangxiao He et al.   ADVANCED FUNCTIONAL MATERIALS

Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells

(2019) M. Feng et al.   Science Advances

Correlating Anticancer Drug Delivery Efficiency with Vascular Permeability of Renal Clearable Versus Non-renal Clearable Nanocarriers

(2019) Chuanqi Peng et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

A tetrameric protein scaffold as a nano-carrier of antitumor peptides for cancer therapy

(2019) Bohan Ma et al.   BIOMATERIALS

A lanthanide-peptide-derived bacterium-like nanotheranostic with high tumor-targeting, -imaging and -killing properties

(2019) Wangxiao He et al.   BIOMATERIALS

Modulating Protein–Protein Interactions In Vivo via Peptide-Lanthanide-Derived Nanoparticles for Hazard-Free Cancer Therapy

(2019) Guang Yang et al.   Journal of Biomedical Nanotechnology

A Hierarchical Peptide–Lanthanide Framework To Accurately Redress Intracellular Carcinogenic Protein–Protein Interaction

(2019) Jin Yan et al.   NANO LETTERS

Biomimetic and Self-Assembled Nanoclusters Targeting β-Catenin for Potent Anticancer Therapy and Enhanced Immunotherapy

(2019) Jiaxin Liu et al.   NANO LETTERS

The Role of TLRs in Anti-cancer Immunity and Tumor Rejection

(2019) Zuzanna Urban-Wojciuk et al.   Frontiers in Immunology

Self-Assembled Peptide–Lanthanide Nanoclusters for Safe Tumor Therapy: Overcoming and Utilizing Biological Barriers to Peptide Drug Delivery

(2018) Jin Yan et al.   ACS Nano

Peptide-Induced Self-Assembly of Therapeutics into a Well-Defined Nanoshell with Tumor-Triggered Shape and Charge Switch

(2018) Wangxiao He et al.   CHEMISTRY OF MATERIALS

Turning a Luffa Protein into a Self-Assembled Biodegradable Nanoplatform for Multitargeted Cancer Therapy

(2018) Wangxiao He et al.   ACS Nano

Wnt–β-catenin signalling in liver development, health and disease

(2018) Maria J. Perugorria et al.   Nature Reviews Gastroenterology & Hepatology

IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade

(2017) Mark Ayers et al.   JOURNAL OF CLINICAL INVESTIGATION

Monitoring immune-checkpoint blockade: response evaluation and biomarker development

(2017) Mizuki Nishino et al.   Nature Reviews Clinical Oncology

Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway

(2016) Vassiliki A. Boussiotis   NEW ENGLAND JOURNAL OF MEDICINE

Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma

(2016) Jesse M. Zaretsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

(2015) Stefani Spranger et al.   NATURE

The future of immune checkpoint therapy

(2015) P. Sharma et al.   SCIENCE

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

(2014) Roy S. Herbst et al.   NATURE

Photocatalytic and antibacterial properties of Au-TiO2 nanocomposite on monolayer graphene: From experiment to theory

(2013) Wangxiao He et al.   JOURNAL OF APPLIED PHYSICS

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

β-Catenin Signaling Controls Metastasis in Braf-Activated Pten-Deficient Melanomas

(2011) William E. Damsky et al.   CANCER CELL

An immune-active tumor microenvironment favors clinical response to ipilimumab

(2011) Rui-Ru Ji et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Dynamic combinatorial chemistry as a tool for the design of functional materials and devices

(2011) Emilie Moulin et al.   CHEMICAL SOCIETY REVIEWS

Delivering nanomedicine to solid tumors

(2010) Rakesh K. Jain et al.   Nature Reviews Clinical Oncology

Immunogenic anti-cancer chemotherapy as an emerging concept

(2008) Nicole M Haynes et al.   CURRENT OPINION IN IMMUNOLOGY

Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy

(2008) Kyung Hyun Min et al.   JOURNAL OF CONTROLLED RELEASE